Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Conjugated oestrogens / progestogen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Conj oestrogens 300microg/Medroxyprogesterone 1.5mg MR tab
0604011Q0AAAHAH
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | 391 |
|
Conj oestrogens 1.25mg tab and Norgestrel 150microg tab
0604011Q0AAADAD
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conj oestrogens 625microg tab and Norgestrel 150microg tab
0604011Q0AAACAC
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conjugated oestrogens 625microg/Medroxyprogesterone 5mg tab
0604011Q0AAAEAE
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Generic Premique Cycle tablets
0604011Q0AAAGAG
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.